ORIX Corporation IX NYSE

ORIX Corporation (IX) generated $0.00 in operating cash flow for quarter ending 2025-12-31. After capital expenditures of $0.00, free cash flow was $0.00.

Free cash flow margin was 0% of revenue.

Criteria supported by this page:

• HEALTH (67/100, Partial) — cash generation is adequate but may not fully cover debt in stressed conditions
• MOAT (81/100, Pass) — $0.00 (0% margin) supports a durable competitive advantage

Overall SharesGrow Score: 73/100 with 4/7 criteria passed.